Basic Information
| LncRNA/CircRNA Name | VPS9D1-AS1 |
| Synonyms | VPS9D1-AS1, MYU |
| Region | GRCh38_16:89711856-89718165 |
| Ensemble | ENSG00000261373 |
| Refseq | NR_036480 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | gastric cancer tissues, cell line (GES1) |
| Expression Pattern | down-regulated |
| Function Description | VPS9D1-AS1 expression level was markedly correlated with tumor size and TNM stage in gastric cancer.low expression of VPS9D1-AS1 were correlated with poor overall and disease free survival. |
| Pubmed ID | 29036784 |
| Year | 2017 |
| Title | Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. |
External Links
| Links for VPS9D1-AS1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |